A Phase I PK and Mass Balance Study of [14C]-selumetinib (QBR115579)

• Research type

  Research Study

• Full title

  A Phase I, Single-centre, Non-randomised, Open-label, Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-selumetinib in Healthy Male Volunteers

• IRAS ID

  136295

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  AstraZeneca AB

• Eudract number

  2013-003242-16

• REC name

  HSC REC B

• REC reference

  13/NI/0124

• Date of REC Opinion

  14 Oct 2013

• REC opinion

  Further Information Favourable Opinion